Lobbying Relationship

Client

BIOGEN

More records

Lobbying firm

Biogen

More records

  • Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis and appropriations, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation (P.L.117-1769), including provisions related to corporate taxes, Medicare, research and development, and prescription drug pricing The Mental Health Professionals Workforce Shortage Loan Repayment Act S.1214, RARE Act S.3558, BioSecure Act
  • Issues related to the 340B program reforms
  • Drug cost and pricing policy S.1967, PBM Act S.1542, DRUG Act H.R.5539, ORPHAN Cures Act Education and discussions regarding pharmaceutical issues related to supply chain H.R.830, HELP Copays Act
  • Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) American Innovations and Jobs Act issues related to OECD negotiations on the taxation of global income
  • Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number
  • Support stronger IP and exclusivity protections and enforcement in foreign markets

Duration: to

General Issues: Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Trade (Domestic & Foreign), Copyright/Patent/Trademark, Transportation, Budget/Appropriations

Spending: about $39,411,680 (But it's complicated. Here's why.)

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), U.S. Trade Representative (USTR), Commerce - Dept of (DOC), Health & Human Services - Dept of (HHS), Patent & Trademark Office (PTO), U.S. Senate,, Natl Economic Council (NEC), U.S. Trade Representative (USTR),, Treasury - Dept of, House of Representatives,

Bills mentioned

H.R.9: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

H.R.1281: Skills First Act of 2015

Sponsor: John Carney (D-Del.)

S.1417: United States Grain Standards Act Reauthorization Act of 2015

Sponsor: Pat Roberts (R-Kan.)

S.320: Medical Innovation Act of 2015

Sponsor: Elizabeth Warren (D-Mass.)

H.R.744: Medical Innovation Act of 2015

Sponsor: Chris Van Hollen (D-Md.)

H.R.1281: Newborn Screening Saves Lives Reauthorization Act of 2014

Sponsor: Lucille Roybal-Allard (D-Calif.)

S.1417: Newborn Screening Saves Lives Reauthorization Act of 2013

Sponsor: Kay Hagan (D-N.C.)

H.R.3309: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

S.1720: Patent Transparency and Improvements Act of 2013

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.6621: To correct and improve certain provisions of the Leahy-Smith America...

Sponsor: Lamar Smith (R-Texas)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.5651: Food and Drug Administration Reform Act of 2012

Sponsor: Fred Upton (R-Mich.)

S.23: America Invents Act

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1249: Leahy-Smith America Invents Act

Sponsor: Lamar Smith (R-Texas)

S.515: Patent Reform Act of 2009

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1260: Patent Reform Act of 2009

Sponsor: John Conyers Jr. (D-Mich.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4872: Health Care and Education Reconciliation Act of 2010

Sponsor: John M. Spratt Jr. (D-S.C.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

S.1679: Affordable Health Choices Act

Sponsor: Tom Harkin (D-Iowa)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

S.301: Physician Payments Sunshine Act of 2009

Sponsor: Charles E. Grassley (R-Iowa)

H.R.1: American Recovery and Reinvestment Act of 2009

Sponsor: David R. Obey (D-Wis.)

S.1695: A bill to authorize the award of a Congressional gold medal to the...

Sponsor: Roland W. Burris (D-Ill.)

S.726: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Charles E. Schumer (D-N.Y.)

S.1695: Biologics Price Competition and Innovation Act of 2007

Sponsor: Edward M. Kennedy (D-Mass.)

H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007

Sponsor: Jay Inslee (D-Wash.)

H.R.1038: Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.5629: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

S.1145: Patent Reform Act of 2007

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1908: Patent Reform Act of 2007

Sponsor: Howard L. Berman (D-Calif.)

H.R.3436: Chronic Care Management Improvement Act

Sponsor: Suzan K. DelBene (D-Wash.)

H.R.987: Strengthening Health Care and Lowering Prescription Drug Costs Act

Sponsor: Lisa Blunt Rochester (D-Del.)

S.1227: Prescription Pricing for the People Act of 2019

Sponsor: Charles E. Grassley (R-Iowa)

H.R.2376: Prescription Pricing for the People Act of 2019

Sponsor: Doug Collins (R-Ga.)

S.1416: Affordable Prescriptions for Patients Act of 2019

Sponsor: John Cornyn (R-Texas)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

S.2543: Prescription Drug Pricing Reduction Act of 2019

Sponsor: Charles E. Grassley (R-Iowa)

H.R.3772: Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019

Sponsor: Scott Peters (D-Calif.)

H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020

Sponsor: Nita M. Lowey (D-N.Y.)

H.R.6201: Families First Coronavirus Response Act

Sponsor: Nita M. Lowey (D-N.Y.)

H.R.748: CARES Act

Sponsor: Joe Courtney (D-Conn.)

H.R.19: Lower Costs, More Cures Act of 2019

Sponsor: Greg Walden (R-Ore.)

H.R.1425: Patient Protection and Affordable Care Enhancement Act

Sponsor: Angie Craig (D-Minn.)

S.4049: National Defense Authorization Act for Fiscal Year 2021

Sponsor: James M. Inhofe (R-Okla.)

H.R.6395: William M. (Mac) Thornberry National Defense Authorization Act for...

Sponsor: Adam Smith (D-Wash.)

H.R.6179: Increasing Access to Biosimilars Act of 2020

Sponsor: Tony Cárdenas (D-Calif.)

H.R.4597: ACCESS for Biosimilars Act of 2019

Sponsor: Scott Peters (D-Calif.)

S.3466: Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars...

Sponsor: Martha McSally (R-Ariz.)

H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent...

Sponsor: Hank Johnson (D-Ga.)

S.3129: Lower Costs, More Cures Act of 2019

Sponsor: Michael D. Crapo (R-Idaho)

H.R.1520: Further Extension of Continuing Appropriations Act, 2021

Sponsor: Anna G. Eshoo (D-Calif.)

S.1895: Lower Health Care Costs Act

Sponsor: Lamar Alexander (R-Tenn.)

S.2546: Safe Step Act

Sponsor: Lisa Murkowski (R-Alaska)

H.R.2279: Safe Step Act

Sponsor: Raul Ruiz (D-Calif.)

H.R.7647: To provide for a COVID-19-related delay regarding annual limitation on...

Sponsor: A. Donald McEachin (D-Va.)

S.4295: Public Health Emergency Pass-Through Payment Fairness Act of 2020

Sponsor: Rand Paul (R-Ky.)

H.R.133: Consolidated Appropriations Act, 2021

Sponsor: Henry Cuellar (D-Texas)

H.R.1319: American Rescue Plan Act of 2021

Sponsor: John Yarmuth (D-Ky.)

H.CON.RES.11: Establishing the congressional budget for the United States Government...

Sponsor: John Yarmuth (D-Ky.)

S.1427: Increasing Access to Biosimilars Act of 2021

Sponsor: John Cornyn (R-Texas)

H.R.2869: Increasing Access to Biosimilars Act of 2021

Sponsor: Tony Cárdenas (D-Calif.)

H.R.2815: BIOSIM Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.2855: Star Rating for Biosimilars Act

Sponsor: Paul Tonko (D-N.Y.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.19: Lower Costs, More Cures Act of 2021

Sponsor: Cathy McMorris Rodgers (R-Wash.)

S.2543: A bill to require a study on the national security implications of the...

Sponsor: Bill Hagerty (R-Tenn.)

S.CON.RES.14: A concurrent resolution setting forth the congressional budget for the...

Sponsor: Bernard Sanders (ID-Vt.)

H.R.5376: Inflation Reduction Act of 2022

Sponsor: John Yarmuth (D-Ky.)

H.R.6179: To prohibit the use of funds for the 2022 and 2026 World Cup until the...

Sponsor: Matt Gaetz (R-Fla.)

H.R.7667: Food and Drug Amendments of 2022

Sponsor: Anna G. Eshoo (D-Calif.)

S.4348: FDASLA Act of 2022

Sponsor: Patty Murray (D-Wash.)

H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act

Sponsor: Jerrold Nadler (D-N.Y.)

H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act...

Sponsor: David Cicilline (D-R.I.)

H.R.2883: Stop Stalling Access to Affordable Medications

Sponsor: Hakeem Jeffries (D-N.Y.)

H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent...

Sponsor: Hank Johnson (D-Ga.)

S.2891: Restoring the America Invents Act

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.4373: Further Additional Continuing Appropriations and Extensions Act, 2023

Sponsor: Barbara Lee (D-Calif.)

S.127: Pharmacy Benefit Manager Transparency Act of 2023

Sponsor: Maria Cantwell (D-Wash.)

S.1214: RARE Act

Sponsor: Tammy Baldwin (D-Wis.)

S.1339: Pharmacy Benefit Manager Reform Act

Sponsor: Bernard Sanders (ID-Vt.)

S.1067: Ensuring Timely Access to Generics Act of 2023

Sponsor: Jeanne Shaheen (D-N.H.)

S.1114: Expanding Access to Low-Cost Generics Act of 2023

Sponsor: Tina Smith (D-Minn.)

S.113: Prescription Pricing for the People Act of 2023

Sponsor: Charles E. Grassley (R-Iowa)

H.R.830: Help Ensure Lower Patient Copays Act

Sponsor: Buddy Carter (R-Ga.)

H.R.485: Protecting Health Care for All Patients Act of 2023

Sponsor: Cathy McMorris Rodgers (R-Wash.)

S.1542: DRUG Act

Sponsor: Roger Marshall (R-Kan.)

H.R.5539: Optimizing Research Progress Hope And New Cures Act

Sponsor: John Joyce (R-Pa.)

S.3558: A bill to prohibit contracting with certain biotechnology providers, and...

Sponsor: Gary Peters (D-Mich.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Adam Brand Chief of Staff, Rep. Linda Sanchez Chief of Staff, Rep. Patrick Kennedy Communications staff, House Minority Leader Richard Gephardt Chief of Staff, Rep. Linda Sanchez & Rep. Patrick Kennedy Chief of Staff, Rep. Linda Sanchez (CA-38)
Catherine Phillips Legislative Assistant, Sen. Tim Scott Legislative Assistant, Rep. Tim Scott
Adam Gluck Professional Staff, Senate Help Committee Professional Staff, Senate Appropriations Committee Legislative Director, Rep. Gene Green Legislative Assistant, Rep. Dale Kildee Staff, Senate HELP Committe Staff, Senate HELP Committee LA, Rep Dale Kildee Staff, House Energy and Commerce Cte LD, Rep Gene Green Staff, House Energy and Commerce Committee
Amy Efantis Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett
Kathleen Tregoning Staff, House Committee on Ways & Means Staff, House Ways and Means Committee
Ally Mendenhall Legislative Assistant, Sen. Mike Johanns (NE)
Kathleen Weldon Staff, House Ways and Means Committee Staff, House Energy and Commerce Cte Staff, Senate Budget Committee Staff, House Energy and Commerce Committee
Sarah D'Orsie Clerk, House Committee on Oversight & Government Reform, Subcommittee on Government Efficiency and Financial Management; Deputy Clerk, House Committee on Oversight Government Reform
Stephanie Dyson Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
Jon Causey Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
Jonathon Causey Hon. Larry Bucshon - Chief of Staff, Senator Elizabeth Dole - Legislative Director--Hon. Patrick McHenry - Chief of Staff---Hon. Robin Hayes - Legislative Senator , Hon. Jesse Helms - Hon, Howard Coble
Tyler Hanson Office of Rep. McNerney 6/2015 - 2/2017
Daniel Harder Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018 Committee on Ways and Means, Clerk, 2/2014-12/2014 Rep. Michael Bishop, LA and LD, 1/2015-4/2018
JOHN GIBSON n/a
Michelle Mathy n/a
Jonathan Causey n/a
Christina Hochul n/a
Amy Demske n/a
Chuck Shih n/a
Caroline Tucker n/a
Susan Kornetsky n/a
Amy Abadir n/a
Ali Lakhani n/a
Aaron Badida n/a
Kathleen Konka n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page